<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36384641</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2397-7523</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Nov</Month><Day>17</Day></PubDate></JournalIssue><Title>Diagnostic and prognostic research</Title><ISOAbbreviation>Diagn Progn Res</ISOAbbreviation></Journal><ArticleTitle>Development and validation of a prognostic model for the early identification of COVID-19 patients at risk of developing common long COVID symptoms.</ArticleTitle><Pagination><StartPage>22</StartPage><MedlinePgn>22</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41512-022-00135-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The coronavirus disease 2019 (COVID-19) pandemic demands reliable prognostic models for estimating the risk of long COVID. We developed and validated a prediction model to estimate the probability of known common long COVID symptoms at least 60 days after acute COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The prognostic model was built based on data from a multicentre prospective Swiss cohort study. Included were adult patients diagnosed with COVID-19 between February and December 2020 and treated as outpatients, at ward or intensive/intermediate care unit. Perceived long-term health impairments, including reduced exercise tolerance/reduced resilience, shortness of breath and/or tiredness (REST), were assessed after a follow-up time between 60 and 425 days. The data set was split into a derivation and a geographical validation cohort. Predictors were selected out of twelve candidate predictors based on three methods, namely the augmented backward elimination (ABE) method, the adaptive best-subset selection (ABESS) method and model-based recursive partitioning (MBRP) approach. Model performance was assessed with the scaled Brier score, concordance c statistic and calibration plot. The final prognostic model was determined based on best model performance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 2799 patients were included in the analysis, of which 1588 patients were in the derivation cohort and 1211 patients in the validation cohort. The REST prevalence was similar between the cohorts with 21.6% (n&#xa0;=&#xa0;343) in the derivation cohort and 22.1% (n&#xa0;=&#xa0;268) in the validation cohort. The same predictors were selected with the ABE and ABESS approach. The final prognostic model was based on the ABE and ABESS selected predictors. The corresponding scaled Brier score in the validation cohort was 18.74%, model discrimination was 0.78 (95% CI: 0.75 to 0.81), calibration slope was 0.92 (95% CI: 0.78 to 1.06) and calibration intercept was -0.06 (95% CI: -0.22 to 0.09).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The proposed model was validated to identify COVID-19-infected patients at high risk for REST symptoms. Before implementing the prognostic model in daily clinical practice, the conduct of an impact study is recommended.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deforth</LastName><ForeName>Manja</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1111-1799</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. manjaelisabeth.deforth@uzh.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebhard</LastName><ForeName>Caroline E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Acute Medicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bengs</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buehler</LastName><ForeName>Philipp K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuepbach</LastName><ForeName>Reto A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zinkernagel</LastName><ForeName>Annelies S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brugger</LastName><ForeName>Silvio D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acevedo</LastName><ForeName>Claudio T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patriki</LastName><ForeName>Dimitri</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Cantonal Hospital Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggli</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Infectiology and Infection Control, Cantonal Hospital Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Twerenbold</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Center of Cardiovascular Science &amp; Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Cardiovascular Research (DZHK) Partner Site Hamburg-Kiel-L&#xfc;beck, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Gabriela M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pargger</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Acute Medicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schefold</LastName><ForeName>Joerg C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spinetti</LastName><ForeName>Thibaud</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wendel-Garcia</LastName><ForeName>Pedro D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofmaenner</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gysi</LastName><ForeName>Bianca</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Acute Medicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siegemund</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Acute Medicine, University Hospital Basel, Basel, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Clinical Research, University of Basel, Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heinze</LastName><ForeName>Georg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Medical Statistics, Informatics and Intelligent Systems, Section for Clinical Biometrics, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Regitz-Zagrosek</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Charit&#xe9;, University Medicine Berlin, Berlin, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gebhard</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular Cardiology, University of Zurich, Schlieren, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Held</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><Identifier Source="ORCID">0000-0003-3105-5840</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics at Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Grant number</GrantID><Agency>The Loop Zurich</Agency><Country/></Grant><Grant><GrantID>196140</GrantID><Agency>Schweizerischer Nationalfonds zur F&#xf6;rderung der Wissenschaftlichen Forschung</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Diagn Progn Res</MedlineTA><NlmUniqueID>101718985</NlmUniqueID><ISSNLinking>2397-7523</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical prediction model</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Prognostic factors</Keyword><Keyword MajorTopicYN="N">Stratified medicine</Keyword></KeywordList><CoiStatement>JCS and TS report grants (full departmental disclosure) from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dr&#xe4;ger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Phagenesis, Nycomed and Cytel outside the submitted work. The money went into departmental funds. No personal financial gain applied. GMK reports grant from Janssen-Cilag. The payment went into institution funds and is unrelated to this work. VRZ report grants from EU Gender Academy, Bundesministerium f&#xfc;r Bildung und Forschung, Springer, Novartis, Pfizer, Lilly, AbbVie and Paul Martini Foundation. The payment went into institution funds and is unrelated to this work. GH is an associate editor of BMC Diagnsotic and Prognostic Research. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36384641</ArticleId><ArticleId IdType="pmc">PMC9668400</ArticleId><ArticleId IdType="doi">10.1186/s41512-022-00135-9</ArticleId><ArticleId IdType="pii">10.1186/s41512-022-00135-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2022. https://covid19.who.int/. Accessed 29 July 2022.</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:1&#x2013;18. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf&#xa0;Hanson S, et al. Long COVID through a public health lens: an umbrella review. Public Health Rev. 2022;43:1&#x2013;10. doi: 10.3389/phrs.2022.1604501.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID). 2021. https://www.who.int/srilanka/news/detail/16-10-2021-post-covid-19-condition. Accessed 20 Jan 2022.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP). COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2022. https://www.nice.org.uk/guidance/NG188. Accessed 28 July 2022.</Citation></Reference><Reference><Citation>Jameson JL, Longo DL. Precision Medicine - Personalized, Problematic, and Promising. N Engl J Med. 2015;372(23):2229&#x2013;34. doi: 10.1056/NEJMsb1503104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb1503104</ArticleId><ArticleId IdType="pubmed">26014593</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyens L, Hackenitz E, Horgan D, Richer E, Brand A, Bu&#xdf;hoff U, et al. CSA PerMed: Europe&#x2019;s commitment to personalised medicine [Journal / periodical articles] Eurohealth. 2014;20(3):41&#x2013;4.</Citation></Reference><Reference><Citation>Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information. 2022. https://pubmed.ncbi.nlm.nih.gov/?term=((prognostic+model[Title])+OR+(prediction+model[Title]))+AND+(development[Title/Abstract]) &amp;sort=relevance. Accessed 25 Mar 2022.</Citation></Reference><Reference><Citation>Wessler BS, Nelson J, Park JG, McGinnes H, Gulati G, Brazil R, et&#xa0;al. External validations of cardiovascular clinical prediction models: a large-scale review of the literature. Circ Cardiovasc Qual Outcome. 2021;14(8). 10.1161/CIRCOUTCOMES.121.007858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8366535</ArticleId><ArticleId IdType="pubmed">34340529</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuzberger N, Damen JA, Trivella M, Estcourt LJ, Aldin A, Umlauff L, et&#xa0;al. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews. 2020;7(7). 10.1002/14651858.CD012022.pub2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8078230</ArticleId><ArticleId IdType="pubmed">32735048</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynants L, Van Calster B, Collins GS, Riley RD, Heinze G, Schuit E, et al. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal. BMJ. 2020;369:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7222643</ArticleId><ArticleId IdType="pubmed">32265220</ArticleId></ArticleIdList></Reference><Reference><Citation>Strijker M, Chen JW, Mungroop TH, Jamieson NB, van Eijck CH, Steyerberg EW, et al. Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer. Br J Surg. 2019;106(4):342&#x2013;54. doi: 10.1002/bjs.11111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.11111</ArticleId><ArticleId IdType="pubmed">30758855</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahey M, Crayton E, Wolfe C, Douiri A. Clinical prediction models for mortality and functional outcome following ischemic stroke: A systematic review and meta-analysis. PLoS ONE. 2018;13(1):1&#x2013;13. doi: 10.1371/journal.pone.0185402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185402</ArticleId><ArticleId IdType="pmc">PMC5788336</ArticleId><ArticleId IdType="pubmed">29377923</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar&#xa0;de Pablo G, Studerus E, Vaquerizo-Serrano J, Irving J, Catalan A, Oliver D, et al. Implementing precision psychiatry: a systematic review of individualized prediction models for clinical practice. Schizophrenia Bulletin. 2021;47(2):284&#x2013;297. doi: 10.1093/schbul/sbaa120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbaa120</ArticleId><ArticleId IdType="pmc">PMC7965077</ArticleId><ArticleId IdType="pubmed">32914178</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KGM. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. Ann Intern Med. 2015;162(1):55&#x2013;63. doi: 10.7326/M14-0697.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0697</ArticleId><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KGM, Altman DG, Reitsma JB, Ioannidis JPA, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Ann Intern Med. 2015;162(1):W1&#x2013;W73. doi: 10.7326/M14-0698.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0698</ArticleId><ArticleId IdType="pubmed">25560730</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Cham: Springer; 2019.</Citation></Reference><Reference><Citation>Riley RD, Snell KI, Ensor J, Burke DL, Harrell FE, Jr, Moons KGM, et al. Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes. Statistics in Medicine. 2019;38(7):1276&#x2013;96. doi: 10.1002/sim.7992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.7992</ArticleId><ArticleId IdType="pmc">PMC6519266</ArticleId><ArticleId IdType="pubmed">30357870</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Debray TPA, Collins GS, Archer L, Ensor J, van Smeden M, et al. Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat Med. 2021;40(19):4230&#x2013;51. doi: 10.1002/sim.9025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.9025</ArticleId><ArticleId IdType="pubmed">34031906</ArticleId></ArticleIdList></Reference><Reference><Citation>Stekhoven DJ, B&#xfc;hlmann P. MissForest - non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(11):112&#x2013;128. doi: 10.1093/bioinformatics/btr597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr597</ArticleId><ArticleId IdType="pubmed">22039212</ArticleId></ArticleIdList></Reference><Reference><Citation>Stekhoven DJ. missForest: nonparametric missing value imputation using random forest. 2013. R package version 1.4.</Citation></Reference><Reference><Citation>Stuart EA, Lee BK, Leacy FP. Prognostic score&#x2013;based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol. 2013;66(Suppl 8):S84&#x2013;S90. doi: 10.1016/j.jclinepi.2013.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2013.01.013</ArticleId><ArticleId IdType="pmc">PMC3713509</ArticleId><ArticleId IdType="pubmed">23849158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie T. gam: Generalized Additive Models. 2020. R package version 1.20.</Citation></Reference><Reference><Citation>Gregorich M, Strohmaier S, Dunkler D, Heinze G. Regression with highly correlated predictors: variable omission is not the solution. Int J Environ Res Public Health. 2021;18(8). https://www.mdpi.com/1660-4601/18/8/4259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8073086</ArticleId><ArticleId IdType="pubmed">33920501</ArticleId></ArticleIdList></Reference><Reference><Citation>Hair JF, Black WC, Babin BJ, Anderson RE, Tatham RL. Multivariate Data Analysis. Upper Saddle River: Prentice Hall; 1998.</Citation></Reference><Reference><Citation>Dunkler D, Plischke M, Leffondr&#xe9; K, Heinze G. Augmented Backward Elimination: A Pragmatic and Purposeful Way to Develop Statistical Models. PLoS ONE. 2014;9(11):1&#x2013;19. doi: 10.1371/journal.pone.0113677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113677</ArticleId><ArticleId IdType="pmc">PMC4240713</ArticleId><ArticleId IdType="pubmed">25415265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu J, Wen C, Zhu J, Zhang H, Wang X. A polynomial algorithm for best-subset selection problem. Proc Natl Acad Sci. 2020;117(52):33117&#x2013;23. doi: 10.1073/pnas.2014241117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2014241117</ArticleId><ArticleId IdType="pmc">PMC7777147</ArticleId><ArticleId IdType="pubmed">33328272</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeileis A, Hothorn T, Hornik K. Model-Based Recursive Partitioning. J Comput Graph Stat. 2008;17(2):492&#x2013;514. doi: 10.1198/106186008X319331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1198/106186008X319331</ArticleId></ArticleIdList></Reference><Reference><Citation>Van&#xa0;Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW. On behalf of Topic Group &#x2018;Evaluating diagnostic tests and prediction models&#x2019; of the STRATOS initiative. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(230):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6912996</ArticleId><ArticleId IdType="pubmed">31842878</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing Vienna, Austria; 2022. https://www.R-project.org/.&#xa0;Accessed 25 May 2022.</Citation></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;13(446):1&#x2013;12. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Kappen TH, van Klei WA, van Wolfswinkel L, Kalkman CJ, Vergouwe Y, Moons KGM. Evaluating the impact of prediction models: lessons learned, challenges, and recommendations. Diagn Prognostic Res. 2018;2(11):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6460651</ArticleId><ArticleId IdType="pubmed">31093561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>